- Home
- WTBA vs ADCT Comparison
WTBA vs ADCT Comparison
Compare WTBA & ADCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WTBA | ADCT |
|---|---|---|
| Founded | 1893 | 2011 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 342.0M | 496.7M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | WTBA | ADCT |
|---|---|---|
| Price | $23.89 | $3.71 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 6 |
| Target Price | ★ $23.50 | $7.60 |
| AVG Volume (30 Days) | 35.4K | ★ 1.7M |
| Earning Date | 01-22-2026 | 11-10-2025 |
| Dividend Yield | ★ 4.17% | N/A |
| EPS Growth | ★ 49.53 | N/A |
| EPS | ★ 1.90 | N/A |
| Revenue | ★ $91,783,000.00 | $75,209,000.00 |
| Revenue This Year | $25.05 | $10.36 |
| Revenue Next Year | $10.87 | $3.87 |
| P/E Ratio | $12.61 | ★ N/A |
| Revenue Growth | ★ 19.66 | 6.35 |
| 52 Week Low | $17.31 | $1.05 |
| 52 Week High | $24.00 | $4.80 |
Technical Indicators
Market Signals| Indicator | WTBA | ADCT |
|---|---|---|
| Relative Strength Index (RSI) | 69.45 | 44.25 |
| Support Level | $23.47 | $3.15 |
| Resistance Level | $22.75 | $4.28 |
| Average True Range (ATR) | 0.51 | 0.40 |
| MACD | 0.12 | 0.00 |
| Stochastic Oscillator | 79.24 | 45.83 |
Price Performance
Historical ComparisonAbout WTBA West Bancorporation
West Bancorp Inc is a United States-based company that offers a full range of deposit services, including checking, savings and money market accounts and time certificates of deposit. West Bank also offers online banking, mobile banking, and treasury management services, which help to meet the banking needs of its customers. Treasury management services offered to business customers include cash management, client-generated automated clearing house transactions, remote deposit, and fraud protection services. Also offered are merchant credit card processing and corporate credit cards. The bank operates only in the United States of America region.
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).